Ahmad Hushki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmad Hushki has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Reema Tayyem
Department of Nutrition Sciences, College of Health Sciences, Qatar University, Doha 2713, Qatar
4 shared publications - Sabika Allehdan
Department of Biology, College of Science, University of Bahrain, Sakhir P.O. Box 32038, Bahrain
3 shared publications - Hiba Bawadi
Department of Human Nutrition, college of health Science, QU-health, Qatar University, Doha, Qatar
2 shared publications - Tareq Al-Jaberi
Faculty of Medicine, Jordan University of Science and Technology and King Abdulla University Hospital, Irbid, Jordan
2 shared publications - Ali Dabous
Department of Surgery, Amman, Jordan
1 shared publication - Ali Shamseddine
Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
1 shared publication
Latest Publications
- Open Access
- 27 February 2025
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 9 (2) , 87
Investigating the dietary links to pancreatic cancer: A case–control study on dairy, meat, and egg consumption
Research has demonstrated that the intake of specific foods and nutrients is linked to the risk of pancreatic cancer, but the role of meat and dairy consumption in pancreatic carcinogenesis remains controversial. The main objective of this study is to investigate the association between the intake of dairy products and meats and the risk of pancreatic cancer. A case–control study was conducted between March 2015 and August 2018 at four main hospitals in Jordan; one of the hospitals was an oncology center. Participants in the study included 101 histologically confirmed pancreatic cancer patients, which were frequency-matched with 314 controls. The required information for this study was gathered through questionnaires based on face-to-face interviews. An Arabic food-frequency questionnaire that has been validated was used to collect data on the intake of different food items from dairy and meat groups. Multinomial logistic regression was employed to determine odds ratios (ORs) and their corresponding 95% confidence intervals (CIs), considering potential confounders. The consumption of different levels and frequencies of yogurt, white cheese, processed cheese, red meats, and chicken was observed to increase the risk of pancreatic cancer. The adjusted OR indicated that the risk of pancreatic cancer was positively related to a daily intake of yogurt (OR: 2.88 [95%CI: 1.40 – 5.91; p = 0.001]), cooked lamb meat (OR: 2.50 [95%CI: 1.30 – 4.84; p = 0.002]), and cooked veal meat (OR: 1.72 [95%CI: 1.11 – 3.77; p = 0.011]). Furthermore, daily and weekly consumption of white cheese, processed cheese, and cooked chicken may be associated with an increased risk of pancreatic cancer. According to the study’s findings, the consumption of yogurt, white cheese, processed cheese, red meat, and chicken was linked to a higher risk of developing pancreatic cancer.
- 27 February 2025
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 9 (2) , 87
Open AccessInvestigating the dietary links to pancreatic cancer: A case–control study on dairy, meat, and egg consumption
Research has demonstrated that the intake of specific foods and nutrients is linked to the risk of pancreatic cancer, but the role of meat and dairy consumption in pancreatic carcinogenesis remains controversial. The main objective of this study is to investigate the association between the intake of dairy products and meats and the risk of pancreatic cancer. A case–control study was conducted between March 2015 and August 2018 at four main hospitals in Jordan; one of the hospitals was an oncology center. Participants in the study included 101 histologically confirmed pancreatic cancer patients, which were frequency-matched with 314 controls. The required information for this study was gathered through questionnaires based on face-to-face interviews. An Arabic food-frequency questionnaire that has been validated was used to collect data on the intake of different food items from dairy and meat groups. Multinomial logistic regression was employed to determine odds ratios (ORs) and their corresponding 95% confidence intervals (CIs), considering potential confounders. The consumption of different levels and frequencies of yogurt, white cheese, processed cheese, red meats, and chicken was observed to increase the risk of pancreatic cancer. The adjusted OR indicated that the risk of pancreatic cancer was positively related to a daily intake of yogurt (OR: 2.88 [95%CI: 1.40 – 5.91; p = 0.001]), cooked lamb meat (OR: 2.50 [95%CI: 1.30 – 4.84; p = 0.002]), and cooked veal meat (OR: 1.72 [95%CI: 1.11 – 3.77; p = 0.011]). Furthermore, daily and weekly consumption of white cheese, processed cheese, and cooked chicken may be associated with an increased risk of pancreatic cancer. According to the study’s findings, the consumption of yogurt, white cheese, processed cheese, red meat, and chicken was linked to a higher risk of developing pancreatic cancer.
- Open Access
- 2 December 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (48) , e31886
Dietary patterns associated with the risk of pancreatic cancer: Case-control study findings
Diet is an important modifiable lifestyle factor, but epidemiological studies evaluating the association between dietary patterns and pancreatic cancer (PC) have reported inconsistent findings. This study aimed to evaluate the impact of several dietary choices on the risk of PC among newly diagnosed Jordanian patients. A case-control study was conducted at major teaching and general hospitals, including a Jordanian oncology center. The study included 101 patients with incident pancreatic cancer and 314 controls. Data was collected using interview-based questionnaires. Dietary intake was estimated using a validated Arabic and reproducible food-frequency questionnaire. Dietary patterns were derived using Principal Component Analysis. Multinomial logistic regression was used to estimate the association between dietary patterns and PC. Four dietary patterns were identified. The “Traditional” dietary pattern, which presented a diet rich in fresh fruits, vegetables, milk, yogurt, and lentils, was associated with a significant decrease in the odds of PC (OR = 0.42, 95% CI = 0.21–0.84) for the third quartile compared to first one. The “High-fruit” dietary pattern, which was loaded with strawberry, melon, watermelon, and other fruits, significantly reduced the odds of PC (OR = 0.38, 95% CI = 0.19–0.75) for the second quartile compared to the first one. The “Soup” dietary pattern was mainly composed of vermicelli soup, vegetable soup, lentil soup, and mushroom soup, which decreased the odds of PC (OR = 0.18, 95% CI = 0.07–0.38). There was no relation between PC and the “Western” dietary pattern, loaded with beer, wine, roasted lamb, meat, chicken sandwich, beefsteak, and fried fish. The “Traditional,” “High-fruit,” and “Soup” dietary patterns were associated with reduced risk of PC among Jordanians.
- 2 December 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (48) , e31886
Open AccessDietary patterns associated with the risk of pancreatic cancer: Case-control study findings
Diet is an important modifiable lifestyle factor, but epidemiological studies evaluating the association between dietary patterns and pancreatic cancer (PC) have reported inconsistent findings. This study aimed to evaluate the impact of several dietary choices on the risk of PC among newly diagnosed Jordanian patients. A case-control study was conducted at major teaching and general hospitals, including a Jordanian oncology center. The study included 101 patients with incident pancreatic cancer and 314 controls. Data was collected using interview-based questionnaires. Dietary intake was estimated using a validated Arabic and reproducible food-frequency questionnaire. Dietary patterns were derived using Principal Component Analysis. Multinomial logistic regression was used to estimate the association between dietary patterns and PC. Four dietary patterns were identified. The “Traditional” dietary pattern, which presented a diet rich in fresh fruits, vegetables, milk, yogurt, and lentils, was associated with a significant decrease in the odds of PC (OR = 0.42, 95% CI = 0.21–0.84) for the third quartile compared to first one. The “High-fruit” dietary pattern, which was loaded with strawberry, melon, watermelon, and other fruits, significantly reduced the odds of PC (OR = 0.38, 95% CI = 0.19–0.75) for the second quartile compared to the first one. The “Soup” dietary pattern was mainly composed of vermicelli soup, vegetable soup, lentil soup, and mushroom soup, which decreased the odds of PC (OR = 0.18, 95% CI = 0.07–0.38). There was no relation between PC and the “Western” dietary pattern, loaded with beer, wine, roasted lamb, meat, chicken sandwich, beefsteak, and fried fish. The “Traditional,” “High-fruit,” and “Soup” dietary patterns were associated with reduced risk of PC among Jordanians.
- Open Access
Macronutrients Intake and Risk of Stomach Cancer: Findings from Case-Control Study
Studies on the association between gastric cancer (GC) and the intake of nutrients in Jordan are very limited, while findings from other reports on the intake of energy and macronutrients are controversial. This study aimed to examine the associations between intake of energy and macronutrients and the risk of GC in a Jordanian population. A case-control study was carried out between March 2015 and August 2018 in four major hospitals, including an oncology center in Jordan. Study participants were 173 cases with incident and histologically confirmed GC and 314 frequency-matched controls. Interview-based questionnaires were used to obtain the study’s information. Data on nutrient intake were collected using a validated Arabic food-frequency questionnaire (FFQ). Odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were calculated through multinomial logistic regression and adjusted for potential confounders, including age, marital status, education, body mass index (BMI), smoking, period of smoking, family history of gastric cancer, history of gastric ulcer, and physical activity. Intakes of total fat, saturated fat, monounsaturated fat, polyunsaturated fat, cholesterol, trans-fat, and omega-6 fatty acids were significantly associated with increased risk of GC. The ORs for the highest versus the lowest tertiles were 6.47 (95% Cl: 3.29–12.77), 2.97 (95% CI: 1.58–5.58), 6.84 (95% CI: 3.46–13.52), 6.19 (95% CI: 3.15–12.17), 3.05 (95% CI: 1.58–5.88), 8.11 (95% CI: 4.20–15.69), and 2.74 (95% CI: 1.47–5.09), respectively. No significant association was found for energy, protein, carbohydrate, sugar, fibers, and omega-3 fatty acids. The findings of this study suggest that high intake of selected types of fats was associated with an increased risk of GC.
Open AccessMacronutrients Intake and Risk of Stomach Cancer: Findings from Case-Control Study
Studies on the association between gastric cancer (GC) and the intake of nutrients in Jordan are very limited, while findings from other reports on the intake of energy and macronutrients are controversial. This study aimed to examine the associations between intake of energy and macronutrients and the risk of GC in a Jordanian population. A case-control study was carried out between March 2015 and August 2018 in four major hospitals, including an oncology center in Jordan. Study participants were 173 cases with incident and histologically confirmed GC and 314 frequency-matched controls. Interview-based questionnaires were used to obtain the study’s information. Data on nutrient intake were collected using a validated Arabic food-frequency questionnaire (FFQ). Odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were calculated through multinomial logistic regression and adjusted for potential confounders, including age, marital status, education, body mass index (BMI), smoking, period of smoking, family history of gastric cancer, history of gastric ulcer, and physical activity. Intakes of total fat, saturated fat, monounsaturated fat, polyunsaturated fat, cholesterol, trans-fat, and omega-6 fatty acids were significantly associated with increased risk of GC. The ORs for the highest versus the lowest tertiles were 6.47 (95% Cl: 3.29–12.77), 2.97 (95% CI: 1.58–5.58), 6.84 (95% CI: 3.46–13.52), 6.19 (95% CI: 3.15–12.17), 3.05 (95% CI: 1.58–5.88), 8.11 (95% CI: 4.20–15.69), and 2.74 (95% CI: 1.47–5.09), respectively. No significant association was found for energy, protein, carbohydrate, sugar, fibers, and omega-3 fatty acids. The findings of this study suggest that high intake of selected types of fats was associated with an increased risk of GC.
- Open Access
- 1 June 2022
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 14, 2017-2029
Mediterranean Dietary Pattern is Associated with Lower Odds of Gastric Cancer: A Case–Control Study
Background: Diet pattern is an important modifiable lifestyle factor. However, epidemiological studies show that the association between dietary patterns and gastric cancer (GC) is conflicting. This study aims to assess the impact of several dietary choices on the risk of GC among newly diagnosed Jordanian patients. Methods: A case–control study was conducted at major oncology centers and hospitals in Jordan. Study participants included 172 patients with incident gastric cancer and 314 controls. Data was collected using interview-based questionnaires. Dietary intake was estimated using a validated Arabic and reproducible food-frequency questionnaire (FFQ). Dietary patterns were derived using Principal Component Analysis (PCA). Multinomial logistic regression was used to estimate the association between dietary patterns and GC. Results: Four dietary patterns were itemized; “Mediterranean”, “Prudent”, “Unhealthy” and “High-fruit” dietary patterns. The “Mediterranean” dietary pattern, which includes a diet rich in fresh fruits, vegetables, milk, yogurt, lentils, and olive oil was associated with a significant decrease in the odds ratio (OR) of GC for the third and fourth quartiles (OR, 0.394 (confidence interval (CI): 0.211– 0.736); 0.212 (CI: 0.107– 0.419), respectively) after adjusting for age, gender, body mass index, smoking, marital status, total energy intake, education level, and physical activity. While the “Unhealthy” and “Prudent” dietary patterns enhance the risk of developing GC, this risk was insignificant at any quartile. Additionally, the “High-Fruit” dietary pattern shows an insignificant protective effect against the risk of GC. Conclusion: The “Mediterranean” dietary pattern was associated with a reduced risk of GC among Jordanians. However, the other three identified dietary patterns were not significantly associated with the risk of GC.
- 1 June 2022
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 14, 2017-2029
Open AccessMediterranean Dietary Pattern is Associated with Lower Odds of Gastric Cancer: A Case–Control Study
Background: Diet pattern is an important modifiable lifestyle factor. However, epidemiological studies show that the association between dietary patterns and gastric cancer (GC) is conflicting. This study aims to assess the impact of several dietary choices on the risk of GC among newly diagnosed Jordanian patients. Methods: A case–control study was conducted at major oncology centers and hospitals in Jordan. Study participants included 172 patients with incident gastric cancer and 314 controls. Data was collected using interview-based questionnaires. Dietary intake was estimated using a validated Arabic and reproducible food-frequency questionnaire (FFQ). Dietary patterns were derived using Principal Component Analysis (PCA). Multinomial logistic regression was used to estimate the association between dietary patterns and GC. Results: Four dietary patterns were itemized; “Mediterranean”, “Prudent”, “Unhealthy” and “High-fruit” dietary patterns. The “Mediterranean” dietary pattern, which includes a diet rich in fresh fruits, vegetables, milk, yogurt, lentils, and olive oil was associated with a significant decrease in the odds ratio (OR) of GC for the third and fourth quartiles (OR, 0.394 (confidence interval (CI): 0.211– 0.736); 0.212 (CI: 0.107– 0.419), respectively) after adjusting for age, gender, body mass index, smoking, marital status, total energy intake, education level, and physical activity. While the “Unhealthy” and “Prudent” dietary patterns enhance the risk of developing GC, this risk was insignificant at any quartile. Additionally, the “High-Fruit” dietary pattern shows an insignificant protective effect against the risk of GC. Conclusion: The “Mediterranean” dietary pattern was associated with a reduced risk of GC among Jordanians. However, the other three identified dietary patterns were not significantly associated with the risk of GC.
- Open Access
- 1 September 2020
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-11
Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma
Background: Current standard practice for locally advanced rectal cancer (LARC) entails a multidisciplinary approach that includes preoperative chemoradiotherapy, followed by total mesorectal excision, and then adjuvant chemotherapy. The latter has been accompanied by low compliance rates and no survival benefit in phase III randomized trials, so the strategy of administering neoadjuvant, rather than adjuvant, chemotherapy has been adapted by many trials, with improvement in pathologic complete response. Induction chemotherapy with oxaliplatin has been shown to have increased efficacy in rectal cancer, while short-course radiation therapy with consolidation chemotherapy increased short-term overall survival rate and decreased toxicity levels, making it cheaper and more convenient than long-course radiation therapy. This led to recognition of total neoadjuvant therapy as a valid treatment approach in many guidelines despite limited available survival data. With the upregulation (PDL-1) expression in rectal tumors after radiotherapy and the increased use of in malignant melanoma, the novel approach of combining immunotherapy with chemotherapy after radiation may have a role in further increasing pCR and improving overall outcomes in rectal cancer. Methods: The study is an open label single arm multi- center phase II trial. Forty-four recruited LARC patients will receive 5Gy x 5fractions of SCRT, followed by 6 cycles of mFOLFOX-6 plus avelumab, before TME is performed. The hypothesis is that the addition of avelumab to mFOLFOX-6, administered following SCRT, will improve pCR and overall outcomes. The primary outcome measure is the proportion of patients who achieve a pCR, defined as no viable tumor cells on the excised specimen. Secondary objectives are to evaluate 3-year progression-free survival, tumor response to treatment (tumor regression grades 0 & 1), density of tumor-infiltrating lymphocytes, correlation of baseline Immunoscore with pCR rates and changes in PD-L1 expression. Discussion: Recent studies show an increase in PD-L1 expression and density of CD8+ TILs after CRT in rectal cancer patients, implying a potential role for combinatory strategies using PD-L1- and programmed-death- 1 inhibiting drugs. We aim through this study to evaluate pCR following SCRT, followed by mFOLFOX-6 with avelumab, and then TME procedure in patients with LARC. Trial registration: Trial Registration Number and Date of Registration: ClinicalTrials.gov NCT03503630, April 20, 2018.
- 1 September 2020
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-11
Open AccessShort-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma
Background: Current standard practice for locally advanced rectal cancer (LARC) entails a multidisciplinary approach that includes preoperative chemoradiotherapy, followed by total mesorectal excision, and then adjuvant chemotherapy. The latter has been accompanied by low compliance rates and no survival benefit in phase III randomized trials, so the strategy of administering neoadjuvant, rather than adjuvant, chemotherapy has been adapted by many trials, with improvement in pathologic complete response. Induction chemotherapy with oxaliplatin has been shown to have increased efficacy in rectal cancer, while short-course radiation therapy with consolidation chemotherapy increased short-term overall survival rate and decreased toxicity levels, making it cheaper and more convenient than long-course radiation therapy. This led to recognition of total neoadjuvant therapy as a valid treatment approach in many guidelines despite limited available survival data. With the upregulation (PDL-1) expression in rectal tumors after radiotherapy and the increased use of in malignant melanoma, the novel approach of combining immunotherapy with chemotherapy after radiation may have a role in further increasing pCR and improving overall outcomes in rectal cancer. Methods: The study is an open label single arm multi- center phase II trial. Forty-four recruited LARC patients will receive 5Gy x 5fractions of SCRT, followed by 6 cycles of mFOLFOX-6 plus avelumab, before TME is performed. The hypothesis is that the addition of avelumab to mFOLFOX-6, administered following SCRT, will improve pCR and overall outcomes. The primary outcome measure is the proportion of patients who achieve a pCR, defined as no viable tumor cells on the excised specimen. Secondary objectives are to evaluate 3-year progression-free survival, tumor response to treatment (tumor regression grades 0 & 1), density of tumor-infiltrating lymphocytes, correlation of baseline Immunoscore with pCR rates and changes in PD-L1 expression. Discussion: Recent studies show an increase in PD-L1 expression and density of CD8+ TILs after CRT in rectal cancer patients, implying a potential role for combinatory strategies using PD-L1- and programmed-death- 1 inhibiting drugs. We aim through this study to evaluate pCR following SCRT, followed by mFOLFOX-6 with avelumab, and then TME procedure in patients with LARC. Trial registration: Trial Registration Number and Date of Registration: ClinicalTrials.gov NCT03503630, April 20, 2018.